Update
$Catheter Precision (VTAK.US)$ FORT MILL, SC / ACCESSWIRE / September 11, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a US based innovative medical device company in the growing field of cardiac electrophysiology, announced its first purchase order from the pacific northwest territory.
As previously announced, the company has recently expanded their US sales and clinical team in preparation for the national product launch of LockeT.
The newest purchase order comes from the MultiCare Health System. The MultiCare Health System includes of 300 specialty care locations and twelve hospitals throughout Washington State, Idaho and Oregon.
"We continue to see continued growth from new hospitals and new territories throughout the US", said David Jenkins, CEO of Catheter Precision. "Early this year we committed to a new sales, marketing and growth strategy for LockeT and we are seeing the positive impact and traction from the newly implemented strategies."
As previously announced, the company has recently expanded their US sales and clinical team in preparation for the national product launch of LockeT.
The newest purchase order comes from the MultiCare Health System. The MultiCare Health System includes of 300 specialty care locations and twelve hospitals throughout Washington State, Idaho and Oregon.
"We continue to see continued growth from new hospitals and new territories throughout the US", said David Jenkins, CEO of Catheter Precision. "Early this year we committed to a new sales, marketing and growth strategy for LockeT and we are seeing the positive impact and traction from the newly implemented strategies."
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
